Fuad El-Hibri
2017
In 2017, Fuad El-Hibri earned a total compensation of $2.6M as Executive Chairman of the Board of Directors at Emergent BioSolutions, a 6% increase compared to previous year.
Compensation breakdown
| Option Awards | $635,307 |
|---|---|
| Salary | $1,023,954 |
| Stock Awards | $899,971 |
| Other | $8,250 |
| Total | $2,567,482 |
El-Hibri received $1M in salary, accounting for 40% of the total pay in 2017.
El-Hibri also received $635.3K in option awards, $900K in stock awards and $8.3K in other compensation.
Rankings
In 2017, Fuad El-Hibri's compensation ranked 4,318th out of 14,666 executives tracked by ExecPay. In other words, El-Hibri earned more than 70.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,318 out of 14,666 | 71st |
Division Manufacturing | 1,514 out of 5,772 | 74th |
Major group Chemicals And Allied Products | 436 out of 2,075 | 79th |
Industry group Drugs | 334 out of 1,731 | 81st |
Industry Pharmaceutical Preparations | 264 out of 1,333 | 80th |
Source: SEC filing on April 12, 2018.
El-Hibri's colleagues
We found five more compensation records of executives who worked with Fuad El-Hibri at Emergent BioSolutions in 2017.
2017
Daniel Abdun-Nabi
Emergent BioSolutions
Chief Executive Officer
2017
Robert Kramer
Emergent BioSolutions
Chief Financial Officer
2017
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
2017
Atul Saran
Emergent BioSolutions
General Counsel
2017
Adam Havey
Emergent BioSolutions